In this groundbreaking episode, JD Enright and Dr. John Osborne welcome a special guest physician to explore the revolutionary world of AI-powered cardiac CT screening. Dr. Osborne, a Harvard-trained cardiologist, shares his unique journey from molecular genetics research to becoming a pioneer in preventive cardiology — revealing why traditional stress tests are failing patients and how ClearCardio's technology is changing everything.
The conversation delivers shocking real-world case studies, including patients with over 1,000 cubic millimeters of plaque who achieved 36% plaque reduction in just one year, and seemingly healthy individuals in their 40s who required emergency bypass surgery despite looking picture-perfect. Dr. Osborne explains how AI can detect over 2,000 shades of gray compared to the human eye's 50, quantifying heart disease down to a tenth of a cubic millimeter and catching disease 20–30 years before symptoms appear.
"AI will see that change long before we can even say it anatomically as far as the degree of narrowing. AI is an early leading indicator. The best news is that if you look at events — ruptured plaques — when you begin to lower cholesterol, the reduction in events begins to occur within days to weeks." — Dr. John Osborne
Key takeaways
- Dr. Osborne trained at Harvard's Brigham and Women's Hospital and spent two years in Harvard's genetics lab identifying genes that cause hypertrophic cardiomyopathy
- One patient reduced total plaque burden by 36.4% in just one year using ClearCardio's protocols
- AI detects over 2,000 shades of gray vs. ~50 for the human eye — quantifying plaque to a tenth of a cubic millimeter
- Texas passed the first heart attack prevention law in 2009, requiring insurance coverage for calcium scoring
Don't wait for symptoms. Look under the hood.